Palantir Technologies Inc. PLTR Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001321655-25-000066
cik 1321655
name PALANTIR TECHNOLOGIES INC.
sic 7372
countryba US
stprba CO
cityba DENVER
zipba 80202
bas1 1200 17TH STREET
bas2 FLOOR 15
baph 720-358-3679
countryma US
stprma CO
cityma DENVER
zipma 80202
mas1 1200 17TH STREET
mas2 FLOOR 15
countryinc
stprinc
ein 680551851
former PALANTIR TECHNOLOGIES INC
changed 20050324
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250506
accepted 2025-05-05 18:15:00.0
prevrpt 0
detail 1
instance pltr-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001321655-25-000066 20250331 Stock Repurchased During Period Shares 211000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20241231 Accrued Liabilities Current 427046000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 125817000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Commitments And Contingencies USD 0 us-gaap/2025
0001321655-25-000066 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class F;
0001321655-25-000066 20241231 Common Stock Shares Authorized 1005000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class F;
0001321655-25-000066 20250331 Common Stock Shares Outstanding 96003000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001321655-25-000066 20240331 Comprehensive Income Net Of Tax 99009000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Cost Of Revenue 116256000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Deferred Revenue Current 259624000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Earnings Per Share Basic 0.0900 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 223316000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Increase Decrease In Contract With Customer Liability -6849000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Investment Income Interest 43352000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Net Cash Provided By Used In Financing Activities 75248000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax -4622000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Profit Loss 3686000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001321655-25-000066 20250331 Revenue From Contract With Customer Excluding Assessed Tax 628494000.0000 USD 1 us-gaap/2025 Concentration Risk By Type= Geographic Concentration Risk; Geographical= U S;
0001321655-25-000066 20240331 Selling And Marketing Expense 193177000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Stockholders Equity 5424155000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2200000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3475561000.0000 USD 0 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -5649613000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001321655-25-000066 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -5544083000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001321655-25-000066 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5094407000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 91132000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001321655-25-000066 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2994000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001321655-25-000066 20250331 Stock Issued During Period Shares Stock Options Exercised 13574000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -10000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20240331 Stock Issued During Period Value Stock Options Exercised 83840000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 155646000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Assets Current 6282599000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Cash And Cash Equivalents At Carrying Value 2098524000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1015005000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class A;
0001321655-25-000066 20241231 Common Stock Shares Authorized 2700000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001321655-25-000066 20241231 Common Stock Shares Outstanding 2338795000.0000 shares 0 us-gaap/2025
0001321655-25-000066 20241231 Common Stock Value 2339000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Common Stock Value 2360000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 541000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Investment Income Interest 50441000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Net Cash Provided By Used In Financing Activities -28897000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Net Income Loss Attributable To Noncontrolling Interest 541000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Operating Income Loss 176048000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Operating Lease Liability Noncurrent 200177000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Operating Lease Right Of Use Asset 209348000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Other Assets Noncurrent 205301000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax -1236000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 3853000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Other Comprehensive Income Loss Net Of Tax -6521000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001321655-25-000066 20250331 Other Liabilities Noncurrent 12489000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Payments To Acquire Property Plant And Equipment 2664000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Proceeds From Sale And Maturity Of Marketable Securities 751746000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Proceeds From Sale And Maturity Of Marketable Securities 350627000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Proceeds From Stock Options Exercised 66584000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Property Plant And Equipment Net 39669000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Retained Earnings Accumulated Deficit -4973392000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Revenue From Contract With Customer Excluding Assessed Tax 335373000.0000 USD 1 us-gaap/2025 Business Segments= Government Operating Segment; Consolidation Items= Operating Segments;
0001321655-25-000066 20240331 Revenue From Contract With Customer Excluding Assessed Tax 63201000.0000 USD 1 us-gaap/2025 Concentration Risk By Type= Geographic Concentration Risk; Geographical= G B;
0001321655-25-000066 20240331 Revenue From Contract With Customer Excluding Assessed Tax 23900000.0000 USD 1 us-gaap/2025 Type Of Arrangement= Investment Agreement; Type Of Contract= Commercial Contract;
0001321655-25-000066 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 801000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001321655-25-000066 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 85404000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001321655-25-000066 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -4973392000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001321655-25-000066 20240331 Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures 9721000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 10000.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Stock Issued During Period Value Stock Options Exercised 66570000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20250331 Stock Repurchased During Period Value 17998000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20250331 Weighted Average Number Of Shares Outstanding Basic 2348679000.0000 shares 1 us-gaap/2025
0001321655-25-000066 20241231 Accounts Payable Current 103000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Common Stock Shares Issued 2359663000.0000 shares 0 us-gaap/2025
0001321655-25-000066 20241231 Common Stock Shares Outstanding 95401000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001321655-25-000066 20250331 Common Stock Shares Outstanding 1005000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class F;
0001321655-25-000066 20241231 Customer Deposit Noncurrent 1663000.0000 USD 0 0001321655-25-000066
0001321655-25-000066 20241231 Deferred Revenue Noncurrent 39885000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 General And Administrative Expense 163639000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Increase Decrease In Other Operating Liabilities -13247000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Liabilities 1246477000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Liabilities 1217944000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Net Cash Provided By Used In Investing Activities -1390277000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Net Income Loss 214031000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Noncash Consideration -11907000.0000 USD 1 0001321655-25-000066
0001321655-25-000066 20240331 Operating Income Loss 80881000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0001321655-25-000066 20241231 Operating Lease Right Of Use Asset 200740000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Other Comprehensive Income Loss Net Of Tax -6521000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Other Comprehensive Income Loss Net Of Tax 2617000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001321655-25-000066 20241231 Other Liabilities Noncurrent 13685000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Other Operating Activities Cash Flow Statement 3531000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Profit Loss 106071000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Revenue From Contract With Customer Excluding Assessed Tax 406389000.0000 USD 1 us-gaap/2025 Concentration Risk By Type= Geographic Concentration Risk; Geographical= U S;
0001321655-25-000066 20250331 Revenue From Contract With Customer Excluding Assessed Tax 883855000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Revenue From Contract With Customer Excluding Assessed Tax 165707000.0000 USD 1 us-gaap/2025 Concentration Risk By Type= Geographic Concentration Risk; Geographical= Rest Of World;
0001321655-25-000066 20250331 Selling And Marketing Expense 236309000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Share Based Compensation 125651000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 10398181000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 7000.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20240331 Stock Issued During Period Value Stock Options Exercised 83823000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20240331 Stock Issued During Period Value Stock Options Exercised 17000.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20240331 Stock Repurchased During Period Shares 368000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Stock Repurchased During Period Value 17998000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20240331 Weighted Average Number Of Diluted Shares Outstanding 2400107000.0000 shares 1 us-gaap/2025
0001321655-25-000066 20241231 Accounts Receivable Net Current 575048000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Assets 6340884000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Accrued Liabilities Current 371061000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Additional Paid In Capital 10193970000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Commitments And Contingencies USD 0 us-gaap/2025
0001321655-25-000066 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class B;
0001321655-25-000066 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class F;
0001321655-25-000066 20241231 Common Stock Shares Authorized 20000000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001321655-25-000066 20241231 Common Stock Shares Issued 2338795000.0000 shares 0 us-gaap/2025
0001321655-25-000066 20241231 Common Stock Shares Issued 1005000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class F;
0001321655-25-000066 20231231 Common Stock Shares Outstanding 2200128000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20240331 Common Stock Shares Outstanding 2226963000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 220334000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Customer Deposit Current 231077000.0000 USD 0 0001321655-25-000066
0001321655-25-000066 20250331 Debt And Equity Securities Unrealized Gain Loss -10688000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Liabilities And Stockholders Equity 6736917000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Liabilities Current 967443000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Marketable Securities Current 3131463000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Net Income Loss Attributable To Noncontrolling Interest 3686000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Operating Income Loss 80881000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Other Nonoperating Income Expense -3173000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Payments Related To Tax Withholding For Share Based Compensation 0.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Payments Related To Tax Withholding For Share Based Compensation 77573000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Property Plant And Equipment Net 39638000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Revenue From Contract With Customer Excluding Assessed Tax 634338000.0000 USD 1 us-gaap/2025 Concentration Risk By Type= Geographic Concentration Risk;
0001321655-25-000066 20240331 Revenue From Contract With Customer Excluding Assessed Tax 164748000.0000 USD 1 us-gaap/2025 Concentration Risk By Type= Geographic Concentration Risk; Geographical= Rest Of World;
0001321655-25-000066 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3560965000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 85945000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001321655-25-000066 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -5611000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001321655-25-000066 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5003275000.0000 USD 0 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2360000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Stock Issued During Period Value Stock Options Exercised 14000.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20240331 Stock Repurchased During Period Value 9000000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Stock Repurchased During Period Value 9000000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 125817000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20250331 Assets 6736917000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Accounts Receivable Net Current 725205000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -2994000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Additional Paid In Capital 10398181000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2119936000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -310442000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Common Stock Shares Authorized 2700000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001321655-25-000066 20250331 Common Stock Shares Outstanding 2262655000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001321655-25-000066 20250331 Common Stock Shares Outstanding 2359663000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 3686000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 99550000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Income Tax Expense Benefit 5599000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Increase Decrease In Accounts Payable And Accrued Liabilities 22395000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Increase Decrease In Accounts Receivable 121884000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Increase Decrease In Accounts Receivable 134959000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -22924000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Net Cash Provided By Used In Operating Activities 310263000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Net Income Loss 105530000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Operating Expenses 437201000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Operating Lease Liability Current 43993000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Other Assets Noncurrent 166217000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -1899000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Payments For Repurchase Of Common Stock 9000000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Profit Loss 105530000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001321655-25-000066 20250331 Profit Loss 217717000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Profit Loss 214031000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001321655-25-000066 20240331 Research And Development Expense 110040000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Research And Development Expense 134889000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Revenue From Contract With Customer Excluding Assessed Tax 298965000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Operating Segment; Consolidation Items= Operating Segments;
0001321655-25-000066 20250331 Revenue From Contract With Customer Excluding Assessed Tax 486963000.0000 USD 1 us-gaap/2025 Business Segments= Government Operating Segment; Consolidation Items= Operating Segments;
0001321655-25-000066 20250331 Revenue From Contract With Customer Excluding Assessed Tax 883855000.0000 USD 1 us-gaap/2025 Concentration Risk By Type= Geographic Concentration Risk;
0001321655-25-000066 20250331 Revenue From Contract With Customer Excluding Assessed Tax 5100000.0000 USD 1 us-gaap/2025 Type Of Arrangement= Investment Agreement; Type Of Contract= Commercial Contract;
0001321655-25-000066 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3861172000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3775227000.0000 USD 0 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 10193970000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5424155000.0000 USD 0 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20250331 Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures 7505000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Stock Issued During Period Shares Stock Options Exercised 13574000.0000 shares 1 us-gaap/2025
0001321655-25-000066 20250331 Stock Issued During Period Value Stock Options Exercised 66584000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20240331 Weighted Average Number Of Shares Outstanding Basic 2213545000.0000 shares 1 us-gaap/2025
0001321655-25-000066 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -5611000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 155646000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 155646000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20240331 Cash And Cash Equivalents At Carrying Value 520388000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Cash And Cash Equivalents At Carrying Value 993464000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -1104931000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Common Stock Shares Authorized 22701005000.0000 shares 0 us-gaap/2025
0001321655-25-000066 20241231 Common Stock Shares Outstanding 2338795000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Comprehensive Income Net Of Tax 216648000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Debt And Equity Securities Unrealized Gain Loss -12354000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Depreciation Depletion And Amortization 8438000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Earnings Per Share Diluted 0.0400 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Gross Profit 710885000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 110726000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Income Tax Expense Benefit 4655000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Increase Decrease In Contract With Customer Liability 18760000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Increase Decrease In Other Operating Liabilities -15515000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Liabilities And Stockholders Equity 6340884000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Marketable Securities Current 4437225000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Net Cash Provided By Used In Investing Activities -511245000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Operating Expenses 5000000.0000 USD 1 us-gaap/2025 Related Party Transactions By Related Party= Chief Executive Officer;
0001321655-25-000066 20241231 Operating Lease Liability Noncurrent 195226000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Other Comprehensive Income Loss Net Of Tax 2617000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20240331 Payments For Proceeds From Other Investing Activities 0.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Payments For Repurchase Of Common Stock 17998000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Proceeds From Payments For Other Financing Activities 90000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Proceeds From Stock Options Exercised 83840000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -5187423000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001321655-25-000066 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -7000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20250331 Stock Issued During Period Value Stock Options Exercised 66584000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Weighted Average Number Of Diluted Shares Outstanding 2552818000.0000 shares 1 us-gaap/2025
0001321655-25-000066 20250331 Accounts Payable Current 2330000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 125817000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 850107000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 539665000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class B;
0001321655-25-000066 20250331 Common Stock Shares Authorized 20000000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001321655-25-000066 20241231 Common Stock Shares Issued 95401000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001321655-25-000066 20250331 Common Stock Shares Issued 2262655000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001321655-25-000066 20250331 Common Stock Shares Issued 96003000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001321655-25-000066 20250331 Common Stock Shares Issued 1005000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class F;
0001321655-25-000066 20241231 Common Stock Shares Outstanding 1005000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class F;
0001321655-25-000066 20250331 Common Stock Shares Outstanding 2359663000.0000 shares 0 us-gaap/2025
0001321655-25-000066 20250331 Cost Of Revenue 172970000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Customer Deposit Current 265252000.0000 USD 0 0001321655-25-000066
0001321655-25-000066 20250331 Customer Deposit Noncurrent 1463000.0000 USD 0 0001321655-25-000066
0001321655-25-000066 20250331 Deferred Revenue Current 318556000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Deferred Revenue Noncurrent 36372000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Earnings Per Share Basic 0.0500 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Earnings Per Share Diluted 0.0800 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -4024000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 General And Administrative Expense 133984000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Minority Interest 91132000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Minority Interest 94818000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Net Cash Provided By Used In Operating Activities 129579000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Operating Expenses 534837000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Operating Income Loss 176048000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0001321655-25-000066 20240331 Other Operating Activities Cash Flow Statement 5592000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Payments To Acquire Marketable Securities 1260327000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Payments To Acquire Marketable Securities 1704720000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Payments To Acquire Property Plant And Equipment 6184000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Prepaid Expense And Other Assets Current 126705000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Profit Loss 541000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001321655-25-000066 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9122173000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -5720000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001321655-25-000066 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2339000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5518973000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 94818000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0001321655-25-000066 20240331 Stock Issued During Period Value Stock Options Exercised 83840000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20240331 Stock Repurchased During Period Value 9000000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20241231 Assets Current 5934289000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2025 Class Of Stock= Common Class A;
0001321655-25-000066 20250331 Common Stock Shares Authorized 22701005000.0000 shares 0 us-gaap/2025
0001321655-25-000066 20250331 Common Stock Shares Authorized 1005000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class F;
0001321655-25-000066 20241231 Common Stock Shares Issued 2242389000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001321655-25-000066 20241231 Common Stock Shares Outstanding 2242389000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001321655-25-000066 20250331 Depreciation Depletion And Amortization 6622000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3980000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Gross Profit 518082000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Increase Decrease In Accounts Payable And Accrued Liabilities 4704000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets -40730000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Liabilities Current 996018000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20250331 Noncash Consideration -17313000.0000 USD 1 0001321655-25-000066
0001321655-25-000066 20250331 Operating Lease Liability Current 44419000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Other Comprehensive Income Loss Net Of Tax -6521000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20250331 Other Comprehensive Income Loss Net Of Tax 2617000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Other Nonoperating Income Expense -13507000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Payments For Proceeds From Other Investing Activities 30000000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Prepaid Expense And Other Assets Current 129254000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Proceeds From Payments For Other Financing Activities 408000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20240331 Profit Loss 105530000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20250331 Profit Loss 214031000.0000 USD 1 us-gaap/2025 Equity Components= Parent;
0001321655-25-000066 20241231 Retained Earnings Accumulated Deficit -5187423000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Revenue From Contract With Customer Excluding Assessed Tax 634338000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20250331 Revenue From Contract With Customer Excluding Assessed Tax 396892000.0000 USD 1 us-gaap/2025 Business Segments= Commercial Operating Segment; Consolidation Items= Operating Segments;
0001321655-25-000066 20250331 Revenue From Contract With Customer Excluding Assessed Tax 89654000.0000 USD 1 us-gaap/2025 Concentration Risk By Type= Geographic Concentration Risk; Geographical= G B;
0001321655-25-000066 20250331 Share Based Compensation 155339000.0000 USD 1 us-gaap/2025
0001321655-25-000066 20241231 Stockholders Equity 5003275000.0000 USD 0 us-gaap/2025
0001321655-25-000066 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9322803000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001321655-25-000066 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2227000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20240331 Stock Issued During Period Shares Stock Options Exercised 17482000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001321655-25-000066 20250331 Stock Repurchased During Period Value 17998000.0000 USD 1 us-gaap/2025

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Operating Lease Liability Noncurrent us-gaap/2025 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Increase Decrease In Contract With Customer Liability us-gaap/2025 0 0 monetary D D Increase (Decrease) in Contract with Customer, Liability Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.
Net Cash Provided By Used In Investing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.
Cash And Cash Equivalents At Carrying Value us-gaap/2025 0 0 monetary I D Cash and Cash Equivalent Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Earnings Per Share Diluted us-gaap/2025 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Stock Repurchased During Period Value us-gaap/2025 0 0 monetary D D Stock Repurchased During Period, Value Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Property Plant And Equipment Net us-gaap/2025 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
General And Administrative Expense us-gaap/2025 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Commitments And Contingencies us-gaap/2025 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Investment Income Interest us-gaap/2025 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2025 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Additional Paid In Capital us-gaap/2025 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Profit Loss us-gaap/2025 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Minority Interest us-gaap/2025 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Other Operating Activities Cash Flow Statement us-gaap/2025 0 0 monetary D D Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item Amount of cash inflow (outflow) from operating activity, classified as other, in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied.
Payments Related To Tax Withholding For Share Based Compensation us-gaap/2025 0 0 monetary D C Payment, Tax Withholding, Share-Based Payment Arrangement Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.
Depreciation Depletion And Amortization us-gaap/2025 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Comprehensive Income Net Of Tax us-gaap/2025 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Debt And Equity Securities Unrealized Gain Loss us-gaap/2025 0 0 monetary D C Debt and Equity Securities, Unrealized Gain (Loss) Amount of unrealized gain (loss) on investment in debt and equity securities.
Operating Expenses us-gaap/2025 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Payments For Repurchase Of Common Stock us-gaap/2025 0 0 monetary D C Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period.
Payments To Acquire Marketable Securities us-gaap/2025 0 0 monetary D C Payments to Acquire Marketable Securities Amount of cash outflow for purchase of marketable security.
Liabilities Current us-gaap/2025 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Operating Income Loss us-gaap/2025 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Payments For Proceeds From Other Investing Activities us-gaap/2025 0 0 monetary D C Payment for (Proceeds from) Other Investing Activity Amount of cash (inflow) outflow from investing activity, classified as other.
Research And Development Expense us-gaap/2025 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Accounts Receivable Net Current us-gaap/2025 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Cost Of Revenue us-gaap/2025 0 0 monetary D D Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Operating Lease Liability Current us-gaap/2025 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Operating Lease Right Of Use Asset us-gaap/2025 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Liabilities Noncurrent us-gaap/2025 0 0 monetary I C Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Selling And Marketing Expense us-gaap/2025 0 0 monetary D D Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Accrued Liabilities Current us-gaap/2025 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Payments To Acquire Property Plant And Equipment us-gaap/2025 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Increase Decrease In Other Operating Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Other Operating Liabilities Amount of increase (decrease) in operating liabilities classified as other.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2025 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.
Stock Issued During Period Value Stock Options Exercised us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Deferred Revenue Noncurrent us-gaap/2025 0 0 monetary I C Deferred Revenue, Noncurrent Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.
Marketable Securities Current us-gaap/2025 0 0 monetary I D Marketable Securities, Current Amount of investment in marketable security, classified as current.
Other Assets Noncurrent us-gaap/2025 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Proceeds From Sale And Maturity Of Marketable Securities us-gaap/2025 0 0 monetary D D Proceeds from Sale and Maturity of Marketable Securities The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures us-gaap/2025 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2025 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Noncash Consideration 0001321655-25-000066 1 0 monetary D D Noncash Consideration Noncash Consideration
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Increase Decrease In Accounts Receivable us-gaap/2025 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Other Nonoperating Income Expense us-gaap/2025 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Prepaid Expense And Other Assets Current us-gaap/2025 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Deferred Revenue Current us-gaap/2025 0 0 monetary I C Deferred Revenue, Current Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.
Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Stock Repurchased During Period Shares us-gaap/2025 0 0 shares D Stock Repurchased During Period, Shares Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.
Accounts Payable Current us-gaap/2025 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Assets Current us-gaap/2025 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Gross Profit us-gaap/2025 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Share Based Compensation us-gaap/2025 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax us-gaap/2025 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Proceeds From Payments For Other Financing Activities us-gaap/2025 0 0 monetary D D Proceeds from (Payment for) Other Financing Activity Amount of cash inflow (outflow) from financing activity, classified as other.
Proceeds From Stock Options Exercised us-gaap/2025 0 0 monetary D D Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement.
Customer Deposit Current 0001321655-25-000066 1 0 monetary I C Customer Deposit, Current Customer deposit current.
Customer Deposit Noncurrent 0001321655-25-000066 1 0 monetary I C Customer Deposit, Noncurrent Customer deposit noncurrent.
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Retained Earnings Accumulated Deficit us-gaap/2025 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Value us-gaap/2025 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001321655-25-000066 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2025 Cash and cash equivalents 0
0001321655-25-000066 2 4 BS 0 H Marketable Securities Current us-gaap/2025 Marketable securities 0
0001321655-25-000066 2 5 BS 0 H Accounts Receivable Net Current us-gaap/2025 Accounts receivable, net 0
0001321655-25-000066 2 6 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2025 Prepaid expenses and other current assets 0
0001321655-25-000066 2 7 BS 0 H Assets Current us-gaap/2025 Total current assets 0
0001321655-25-000066 2 8 BS 0 H Property Plant And Equipment Net us-gaap/2025 Property and equipment, net 0
0001321655-25-000066 2 9 BS 0 H Operating Lease Right Of Use Asset us-gaap/2025 Operating lease right-of-use assets 0
0001321655-25-000066 2 10 BS 0 H Other Assets Noncurrent us-gaap/2025 Other assets 0
0001321655-25-000066 2 11 BS 0 H Assets us-gaap/2025 Total assets 0
0001321655-25-000066 2 14 BS 0 H Accounts Payable Current us-gaap/2025 Accounts payable 0
0001321655-25-000066 2 15 BS 0 H Accrued Liabilities Current us-gaap/2025 Accrued liabilities 0
0001321655-25-000066 2 16 BS 0 H Deferred Revenue Current us-gaap/2025 Deferred revenue 0
0001321655-25-000066 2 17 BS 0 H Customer Deposit Current 0001321655-25-000066 Customer deposits 0
0001321655-25-000066 2 18 BS 0 H Operating Lease Liability Current us-gaap/2025 Operating lease liabilities 0
0001321655-25-000066 2 19 BS 0 H Liabilities Current us-gaap/2025 Total current liabilities 0
0001321655-25-000066 2 20 BS 0 H Deferred Revenue Noncurrent us-gaap/2025 Deferred revenue, noncurrent 0
0001321655-25-000066 2 21 BS 0 H Customer Deposit Noncurrent 0001321655-25-000066 Customer deposits, noncurrent 0
0001321655-25-000066 2 22 BS 0 H Operating Lease Liability Noncurrent us-gaap/2025 Operating lease liabilities, noncurrent 0
0001321655-25-000066 2 23 BS 0 H Other Liabilities Noncurrent us-gaap/2025 Other noncurrent liabilities 0
0001321655-25-000066 2 24 BS 0 H Liabilities us-gaap/2025 Total liabilities 0
0001321655-25-000066 2 25 BS 0 H Commitments And Contingencies us-gaap/2025 Commitments and Contingencies (Note 7) 0
0001321655-25-000066 2 27 BS 0 H Common Stock Value us-gaap/2025 Common stock 0
0001321655-25-000066 2 28 BS 0 H Additional Paid In Capital us-gaap/2025 Additional paid-in capital 0
0001321655-25-000066 2 29 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Accumulated other comprehensive income (loss), net 0
0001321655-25-000066 2 30 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2025 Accumulated deficit 0
0001321655-25-000066 2 31 BS 0 H Stockholders Equity us-gaap/2025 Total Palantir's stockholders equity 0
0001321655-25-000066 2 32 BS 0 H Minority Interest us-gaap/2025 Noncontrolling interests 0
0001321655-25-000066 2 33 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Total equity 0
0001321655-25-000066 2 34 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 Total liabilities and equity 0
0001321655-25-000066 3 8 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common stock, par value (in dollars per share) 0
0001321655-25-000066 3 9 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common stock, shares authorized (in shares) 0
0001321655-25-000066 3 10 BS 1 H Common Stock Shares Issued us-gaap/2025 Common stock, shares issued (in shares) 0
0001321655-25-000066 3 11 BS 1 H Common Stock Shares Outstanding us-gaap/2025 Common stock, shares outstanding (in shares) 0
0001321655-25-000066 4 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2025 Revenue 0
0001321655-25-000066 4 2 IS 0 H Cost Of Revenue us-gaap/2025 Cost of revenue 0
0001321655-25-000066 4 3 IS 0 H Gross Profit us-gaap/2025 Gross profit 0
0001321655-25-000066 4 5 IS 0 H Selling And Marketing Expense us-gaap/2025 Sales and marketing 0
0001321655-25-000066 4 6 IS 0 H Research And Development Expense us-gaap/2025 Research and development 0
0001321655-25-000066 4 7 IS 0 H General And Administrative Expense us-gaap/2025 General and administrative 0
0001321655-25-000066 4 8 IS 0 H Operating Expenses us-gaap/2025 Total operating expenses 0
0001321655-25-000066 4 9 IS 0 H Operating Income Loss us-gaap/2025 Income from operations 0
0001321655-25-000066 4 10 IS 0 H Investment Income Interest us-gaap/2025 Interest income 0
0001321655-25-000066 4 11 IS 0 H Other Nonoperating Income Expense us-gaap/2025 Other income (expense), net 0
0001321655-25-000066 4 12 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 Income before provision for income taxes 0
0001321655-25-000066 4 13 IS 0 H Income Tax Expense Benefit us-gaap/2025 Provision for income taxes 0
0001321655-25-000066 4 14 IS 0 H Profit Loss us-gaap/2025 Net income 0
0001321655-25-000066 4 15 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 Less: Net income attributable to noncontrolling interests 0
0001321655-25-000066 4 16 IS 0 H Net Income Loss us-gaap/2025 Net income attributable to common stockholders 0
0001321655-25-000066 4 17 IS 0 H Earnings Per Share Basic us-gaap/2025 Net earnings per share attributable to common stockholders, basic (in dollars per share) 0
0001321655-25-000066 4 18 IS 0 H Earnings Per Share Diluted us-gaap/2025 Net earnings per share attributable to common stockholders, diluted (in dollars per share) 0
0001321655-25-000066 4 19 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 Weighted-average shares of common stock outstanding used in computing net earnings per share attributable to common stockholders, basic (in shares) 0
0001321655-25-000066 4 20 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2025 Weighted-average shares of common stock outstanding used in computing net earnings per share attributable to common stockholders, diluted (in shares) 0
0001321655-25-000066 5 1 CI 0 H Profit Loss us-gaap/2025 Net income 0
0001321655-25-000066 5 3 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2025 Foreign currency translation adjustments 0
0001321655-25-000066 5 4 CI 0 H Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax us-gaap/2025 Net unrealized loss on available-for-sale securities 0
0001321655-25-000066 5 5 CI 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Comprehensive income 0
0001321655-25-000066 5 6 CI 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2025 Less: Comprehensive income attributable to noncontrolling interests 0
0001321655-25-000066 5 7 CI 0 H Comprehensive Income Net Of Tax us-gaap/2025 Comprehensive income attributable to common stockholders 0
0001321655-25-000066 6 12 EQ 0 H Common Stock Shares Outstanding us-gaap/2025 Beginning balance (in shares) 0
0001321655-25-000066 6 13 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Beginning balance 0
0001321655-25-000066 6 14 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2025 Issuance of common stock from the exercise of stock options (in shares) 0
0001321655-25-000066 6 15 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2025 Issuance of common stock from the exercise of stock options 0
0001321655-25-000066 6 16 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures us-gaap/2025 Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares) 0
0001321655-25-000066 6 17 EQ 0 H Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures us-gaap/2025 Issuance of common stock upon vesting of restricted stock units (RSUs) 0
0001321655-25-000066 6 18 EQ 0 H Stock Repurchased During Period Shares us-gaap/2025 Repurchases of common stock (in shares) 1
0001321655-25-000066 6 19 EQ 0 H Stock Repurchased During Period Value us-gaap/2025 Repurchases of common stock 1
0001321655-25-000066 6 20 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 Stock-based compensation 0
0001321655-25-000066 6 21 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other comprehensive income (loss) 0
0001321655-25-000066 6 22 EQ 0 H Profit Loss us-gaap/2025 Net income 0
0001321655-25-000066 6 23 EQ 0 H Common Stock Shares Outstanding us-gaap/2025 Ending balance (in shares) 0
0001321655-25-000066 6 24 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Ending balance 0
0001321655-25-000066 7 2 CF 0 H Profit Loss us-gaap/2025 Net income 0
0001321655-25-000066 7 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2025 Depreciation and amortization 0
0001321655-25-000066 7 5 CF 0 H Share Based Compensation us-gaap/2025 Stock-based compensation 0
0001321655-25-000066 7 6 CF 0 H Debt And Equity Securities Unrealized Gain Loss us-gaap/2025 Unrealized and realized (gain) loss from marketable securities, net 1
0001321655-25-000066 7 7 CF 0 H Noncash Consideration 0001321655-25-000066 Noncash consideration 0
0001321655-25-000066 7 8 CF 0 H Other Operating Activities Cash Flow Statement us-gaap/2025 Other operating activities 0
0001321655-25-000066 7 10 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2025 Accounts receivable, net 1
0001321655-25-000066 7 11 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2025 Prepaid expenses and other assets 1
0001321655-25-000066 7 12 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2025 Accounts payable and accrued liabilities 0
0001321655-25-000066 7 13 CF 0 H Increase Decrease In Contract With Customer Liability us-gaap/2025 Contract liabilities 0
0001321655-25-000066 7 14 CF 0 H Increase Decrease In Other Operating Liabilities us-gaap/2025 Other liabilities 0
0001321655-25-000066 7 15 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net cash provided by operating activities 0
0001321655-25-000066 7 17 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2025 Purchases of property and equipment 1
0001321655-25-000066 7 18 CF 0 H Payments To Acquire Marketable Securities us-gaap/2025 Purchases of marketable securities 1
0001321655-25-000066 7 19 CF 0 H Proceeds From Sale And Maturity Of Marketable Securities us-gaap/2025 Proceeds from sales and redemption of marketable securities 0
0001321655-25-000066 7 20 CF 0 H Payments For Proceeds From Other Investing Activities us-gaap/2025 Other investing activities 1
0001321655-25-000066 7 21 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2025 Net cash used in investing activities 0
0001321655-25-000066 7 23 CF 0 H Proceeds From Stock Options Exercised us-gaap/2025 Proceeds from the exercise of common stock options 0
0001321655-25-000066 7 24 CF 0 H Payments For Repurchase Of Common Stock us-gaap/2025 Repurchases of common stock 1
0001321655-25-000066 7 25 CF 0 H Payments Related To Tax Withholding For Share Based Compensation us-gaap/2025 Taxes paid related to net share settlement of equity awards 1
0001321655-25-000066 7 26 CF 0 H Proceeds From Payments For Other Financing Activities us-gaap/2025 Other financing activities 0
0001321655-25-000066 7 27 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net cash provided by (used in) financing activities 0
0001321655-25-000066 7 28 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Effect of foreign exchange on cash, cash equivalents, and restricted cash 0
0001321655-25-000066 7 29 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 Net decrease in cash, cash equivalents, and restricted cash 0
0001321655-25-000066 7 30 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash, cash equivalents, and restricted cash - beginning of period 0
0001321655-25-000066 7 31 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash, cash equivalents, and restricted cash - end of period 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.